The potential of trace amines and their receptors for treating neurological and psychiatric diseases.

  title={The potential of trace amines and their receptors for treating neurological and psychiatric diseases.},
  author={Mark D. Berry},
  journal={Reviews on recent clinical trials},
  volume={2 1},
  • M. D. Berry
  • Published 2007
  • Biology
  • Reviews on recent clinical trials
Mining of the human genome has revealed approximately 7000 novel proteins, which could serve as potential targets for the development of novel therapeutics. Of these, approximately 2000 are predicted to be G-protein coupled receptors. Within this group of proteins, a family of 18 mammalian receptors has recently been identified that appear to exhibit selectivity toward the so-called trace amines. The trace amines are a family of endogenous compounds with strong structural similarity to… 

Tables from this paper

Trace Amines and Their Relevance to Psychiatry and Neurology: A Brief Overview

There has been a resurgence of interest in these amines in the past decade with the discovery and cloning of a unique family of G-protein-coupled receptors, some of which are selectively activated by trace amines; these receptors have been termed trace amine, associated receptors (TAARs).

International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature

This review proposes an official nomenclature designating TAAR1 as the trace amine 1 receptor following the convention of naming receptors after the endogenous agonist, abbreviated to TA1 where necessary.

Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.

The successful expression of human and mouse TAAR1 and the characterization of their responses to various natural and synthetic agonists raise new possibilities about the mechanism of some of the imidazoline-related agents.

Neuronal Functions and Emerging Pharmacology of TAAR1

Brain and peripheral functions mediated by TAAR1 and other TAARs are reviewed, suggesting intriguing novelTAAR1 roles in system physiology.



A renaissance in trace amines inspired by a novel GPCR family.

Trace amines: Identification of a family of mammalian G protein-coupled receptors

Using a degenerate PCR approach, 15 G protein-coupled receptors (GPCR) from human and rodent tissues are identified and it is demonstrated that two of these receptors bind and/or are activated by trace amines.

A Rapid Functional Assay for the Human Trace Amine-Associated Receptor 1 Based on the Mobilization of Internal Calcium

Data indicate that the hTAAR1 retains its reported pharmacological characteristics when coupled to Gα 16, and the EC50 and Emax data obtained for known TAs are in close agreement with previous work using transient hTAar1 expression systems or a chimeric receptor.

Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators

Previous studies showing responses to physiologically relevant concentrations of trace amines are reviewed, along with those showing a reciprocal relationship between trace amine levels and fluctuations in basal monoaminergic tone, and it is hypothesized that the traceAmines function as endogenous neuromodulators of classical monoamine neurotransmitters.

Functional interactions of 2-phenylethylamine and of tryptamine with brain catecholamines: Implications for psychotherapeutic drug action

  • A. Greenshaw
  • Psychology, Biology
    Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 1989

Peptide and trace amine orphan receptors: prospects for new therapeutic targets.

  • A. Davenport
  • Biology, Chemistry
    Current opinion in pharmacology
  • 2003

The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.

  • H. Y. YangN. Neff
  • Biology, Chemistry
    The Journal of pharmacology and experimental therapeutics
  • 1974
It is postulate that it may be possible to alter selectively the metabolism of the putative transmitter amines in man by administration of monoamine oxidase inhibitor drugs that preferentially inactivate a specific type of monoamines.

Pharmacological studies with endogenous enhancer substances: β-phenylethylamine, tryptamine, and their synthetic derivatives

  • S. ShimazuI. Miklya
  • Biology, Chemistry
    Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 2004

2-Phenylethylamine as a possible mediator for Δ9-tetrahydrocannabinol-induced stimulation

IF neuroamines modulate perception and affect, as implied in much of the literature, the behavioural effects of marihuana may be mediated by alterations of brain amine mechanisms, Even in large doses